Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wosnitza

Showing results (111-120 of 117) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 117 results.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2018
Anomalous Hall effect in Weyl semimetal half-Heusler compounds RPtBi (R = Gd and Nd)Chandra Shekhar, Nitesh Kumar, V Grinenko, et al.
Physical Review Letters|October 22, 2021
Magnetic Field Induced Quantum Spin Liquid in the Two Coupled Trillium Lattices of K_{2}Ni_{2}(SO_{4})_{3}Ivica Živković, Virgile Favre, Catalina Salazar Mejia, et al.
Nature Communications|June 8, 2019
Extremely high conductivity observed in the triple point topological metal MoPNitesh Kumar, Yan Sun, Michael Nicklas, et al.
Nature Communications|May 28, 2021
Origin of the quasi-quantized Hall effect in ZrTe<sub>5</sub>S Galeski, T Ehmcke, R Wawrzyńczak, et al.
The Lancet. Rheumatology|January 22, 2024
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trialOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Annals of the Rheumatic Diseases|April 18, 2020
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trialDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
Rheumatology (Oxford, England)|March 9, 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosisDinesh Khanna, Frank Kramer, Josef Höfler, et al.
Pageof 12

Showing results (111-120 of 117) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 117 results.
Proceedings of the National Academy of Sciences of the United States of America|August 30, 2018
Anomalous Hall effect in Weyl semimetal half-Heusler compounds RPtBi (R = Gd and Nd)Chandra Shekhar, Nitesh Kumar, V Grinenko, et al.
Physical Review Letters|October 22, 2021
Magnetic Field Induced Quantum Spin Liquid in the Two Coupled Trillium Lattices of K_{2}Ni_{2}(SO_{4})_{3}Ivica Živković, Virgile Favre, Catalina Salazar Mejia, et al.
Nature Communications|June 8, 2019
Extremely high conductivity observed in the triple point topological metal MoPNitesh Kumar, Yan Sun, Michael Nicklas, et al.
Nature Communications|May 28, 2021
Origin of the quasi-quantized Hall effect in ZrTe<sub>5</sub>S Galeski, T Ehmcke, R Wawrzyńczak, et al.
The Lancet. Rheumatology|January 22, 2024
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): open-label, long-term extension of a phase 2b, randomised, placebo-controlled trialOliver Distler, Yannick Allanore, Christopher P Denton, et al.
Annals of the Rheumatic Diseases|April 18, 2020
Riociguat in patients with early diffuse cutaneous systemic sclerosis (RISE-SSc): randomised, double-blind, placebo-controlled multicentre trialDinesh Khanna, Yannick Allanore, Christopher P Denton, et al.
Rheumatology (Oxford, England)|March 9, 2024
Biomarker analysis from the phase 2b randomized placebo-controlled trial of riociguat in early diffuse cutaneous systemic sclerosisDinesh Khanna, Frank Kramer, Josef Höfler, et al.
Pageof 12